Alzheimer’s disease (AD) is a debilitating neurodegenerative disease, that is clinically characterized by the formation of amyloid-beta (Aβ) plaques and aggregates of hyperphosphorylated tau protein in the brain (Mirra et al., 1991). This evidence concerns the gene MAPT and Alzheimer disease.